A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk Children

Clinical trial NCT03959488 · COMPLETED

Trial details

NCT number: NCT03959488
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2019-07-30
Primary completion: 2021-05-03
Enrollment: 925

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.